trial

Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation

NCTId NCT03114488
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 41 (actual)
Sponsored by University of Minnesota
Primary completion 2018-10-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
41 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2017-12-01
Primary completion
2018-10-05
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
TDCS

Sponsors

University of MinnesotaLead Sponsor

Sites

1 total
Minneapolis, United States

Facts & assertions

4 sourced
Enrollment
41
Phase
NA
Primary Completion Date
2018-10-05
Status
COMPLETED
relationships
The graph out of here
drug
TDCS
drug
lead_sponsor
University of Minnesota
company
indication
Schizophrenia
indication
Healthy
indication
Schizophrenia
indication